These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3512936)

  • 1. Discriminative stimulus properties of amphetamine and structurally related phenalkylamines.
    Young R; Glennon RA
    Med Res Rev; 1986; 6(1):99-130. PubMed ID: 3512936
    [No Abstract]   [Full Text] [Related]  

  • 2. Discrimination of stimulus duration and d-amphetamine in pigeons: a psychophysical analysis.
    Stubbs DA; Thomas JR
    Psychopharmacologia; 1974 May; 36(4):313-22. PubMed ID: 4847385
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of some phenylethylamines in rhesus monkeys trained to discriminate (+)-amphetamine from saline.
    Woolverton WL; English JA
    Drug Alcohol Depend; 1997 Mar; 44(2-3):79-85. PubMed ID: 9088779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulus properties of some analogues of 4-methylaminorex.
    Russell BR; Beresford RA; Schmierer DM; McNaughton N; Clark CR
    Pharmacol Biochem Behav; 1995; 51(2-3):375-8. PubMed ID: 7667356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition and recovery of tolerance to the discriminative stimulus properties of cocaine.
    Wood DM; Lal H; Emmett-Oglesby M
    Neuropharmacology; 1984 Dec; 23(12A):1419-23. PubMed ID: 6527744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EEG and behavioral effects in animals of some amphetamine derivatives with hallucinogenic properties.
    Florio V; Fuentes JA; Ziegler H; Longo VG
    Behav Biol; 1972 Jun; 7(3):401-14. PubMed ID: 5067663
    [No Abstract]   [Full Text] [Related]  

  • 7. Hallucinogens as discriminative stimuli.
    Winter JC
    Fed Proc; 1974 Jul; 33(7):1825-32. PubMed ID: 4209212
    [No Abstract]   [Full Text] [Related]  

  • 8. A description of the nicotine stimulus and tests of its generalization to amphetamine.
    Chance WT; Murfin D; Krynock GM; Rosecrans JA
    Psychopharmacology (Berl); 1977 Nov; 55(1):19-26. PubMed ID: 414257
    [No Abstract]   [Full Text] [Related]  

  • 9. d-Amphetamine discrimination established under a conditional discrimination procedure in pigeons.
    Watanabe S
    Yakubutsu Seishin Kodo; 1983 May; 3(1):45-50. PubMed ID: 6666378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties of tripelennamine in the pigeon.
    Karas CA; Picker M; Poling A
    Psychopharmacology (Berl); 1985; 86(3):356-8. PubMed ID: 2863839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents.
    Goudie AJ; Dubicki W; Leathley M
    J Pharm Pharmacol; 1988 Mar; 40(3):192-6. PubMed ID: 2899149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulus control and the effects of d-amphetamine in the rat.
    Laties VG; Wood RW; Rees DC
    Psychopharmacology (Berl); 1981; 75(3):277-82. PubMed ID: 6798618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of p-chloroamphetamine on instrumental conditioning in the rat.
    Rosen AJ; Freedman PE
    Neuropharmacology; 1974 Jul; 13(7):585-90. PubMed ID: 4437732
    [No Abstract]   [Full Text] [Related]  

  • 14. Discriminative stimulus properties of d-amphetamine and related compounds in rats.
    Huang JT; Ho BT
    Pharmacol Biochem Behav; 1974; 2(5):669-73. PubMed ID: 4431829
    [No Abstract]   [Full Text] [Related]  

  • 15. Behaviourally specific interactions between naloxone and beta-phenylethylamine in an operant drug discrimination procedure in rats.
    Goudie AJ
    Pharmacol Biochem Behav; 1987 Jan; 26(1):199-202. PubMed ID: 3562493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of discriminative stimuli in modulating drug action.
    Laties VG
    Fed Proc; 1975 Aug; 34(9):1880-8. PubMed ID: 1097270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacological analysis of processes underlying differential responding: a review and further experiments with scopolamine, amphetamine, lysergic acid diethylamide (LSD-25), chlordiazepoxide, physostigmine, and chlorpromazine.
    Frontali M; Amorico L; De Acetis L; Bignami G
    Behav Biol; 1976 Sep; 18(1):1-74. PubMed ID: 791242
    [No Abstract]   [Full Text] [Related]  

  • 18. Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine.
    Bensadoun JC; Brooks SP; Dunnett SB
    Psychopharmacology (Berl); 2004 Jul; 174(3):396-405. PubMed ID: 14985934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of drug-state change on discrimination performance.
    Cole SO; Gay PE
    Psychopharmacology (Berl); 1976 May; 47(1):43-7. PubMed ID: 959466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for perceptual masking of the discriminative morphine stimulus.
    Gauvin DV; Young AM
    Psychopharmacology (Berl); 1989; 98(2):212-21. PubMed ID: 2502792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.